| P50 | author | Ashutosh Tewari | Q4806141 |
| | Stefanie J C G Hectors | Q85419361 |
| | Mathilde Wagner | Q88869532 |
| | Bachir Taouli | Q89774727 |
| P2093 | author name string | Wei Huang | |
| | Ardeshir Rastinehad | |
| | Cecilia Besa | |
| | George K Haines | |
| | Guido H Jajamovich | |
| | Sara Lewis | |
| P2860 | cites work | The role of magnetic resonance imaging in the diagnosis and management of prostate cancer | Q26849794 |
| | Overdiagnosis and overtreatment of prostate cancer | Q26859596 |
| | Cancer statistics, 2013 | Q27860762 |
| | Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo | Q30581035 |
| | Intratumor mapping of intracellular water lifetime: metabolic images of breast cancer? | Q30814598 |
| | Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape | Q30885097 |
| | Mapping human brain capillary water lifetime: high-resolution metabolic neuroimaging. | Q30939942 |
| | DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience | Q31030824 |
| | The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge | Q31097630 |
| | Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling | Q31107389 |
| | The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo | Q33384078 |
| | Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging | Q35407336 |
| | Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI. | Q35947118 |
| | The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma | Q36227180 |
| | Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer | Q36404493 |
| | Multiple significance tests: the Bonferroni method | Q36901984 |
| | Applications of transrectal ultrasound in prostate cancer | Q37102542 |
| | Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T. | Q37407972 |
| | A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation. | Q37662706 |
| | Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. | Q38080001 |
| | MR imaging of the prostate | Q38216958 |
| | DCE MRI of prostate cancer. | Q38837802 |
| | Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer | Q39391979 |
| | Improving the arterial input function in dynamic contrast enhanced MRI by fitting the signal in the complex plane. | Q40366516 |
| | Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters. | Q40454478 |
| | Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy | Q41822887 |
| | Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection | Q42434167 |
| | Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T. | Q43525988 |
| | High temporal resolution 3D gadolinium-enhanced dynamic MR imaging of renal tumors with pharmacokinetic modeling: preliminary observations. | Q45968202 |
| | Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla | Q46947325 |
| | Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters | Q46989269 |
| | MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results | Q48013368 |
| | Combining phase and magnitude information for contrast agent quantification in dynamic contrast-enhanced MRI using statistical modeling | Q48482468 |
| | Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts | Q48797418 |
| | Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer. | Q50863441 |
| | Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T. | Q50954987 |
| | Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer. | Q51041919 |
| | Feasibility of CAIPIRINHA-Dixon-TWIST-VIBE for dynamic contrast-enhanced MRI of the prostate. | Q52862784 |
| | Optimal cut-off value of perfusion parameters for diagnosing prostate cancer and for assessing aggressiveness associated with Gleason score. | Q53496757 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 837-849 | |
| P577 | publication date | 2017-01-16 | |
| P1433 | published in | Journal of Magnetic Resonance Imaging | Q15761156 |
| P1476 | title | DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness | |
| P478 | volume | 46 | |